Epigenetic Modification of Death Receptor Genes for TRAIL and TRAIL Resistance in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Immunotherapies specific for B-cell precursor acute lymphoblastic leukemia (BCP-ALL), such as anti-CD19 chimeric antigen receptor (CAR) T-cells and blinatumomab, have dramatically improved the therapeutic outcome in refractory cases. In the anti-leukemic activity of those immunotherapies, TNF-relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Atsushi, Miyake, Kunio, Akahane, Koshi, Goi, Kumiko, Kagami, Keiko, Yagita, Hideo, Inukai, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229974/
https://www.ncbi.nlm.nih.gov/pubmed/34198757
http://dx.doi.org/10.3390/genes12060864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229974/
https://www.ncbi.nlm.nih.gov/pubmed/34198757
http://dx.doi.org/10.3390/genes12060864

Ejemplares similares